Context Therapeutics (CNTX) Change in Account Payables (2020 - 2026)

Context Therapeutics has reported Change in Account Payables for 7 years, with the latest figure at -$67158.0 in Q1 2026.

• Quarterly Change in Account Payables rose 84.58% year-over-year to -$67158.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 240.26% YoY) and the FY2025 annual result came in at $1.1 million, up 215.84% from the prior year.
• Change in Account Payables rose to -$67158.0 in Q1 2026 per CNTX's latest filing, from -$187989.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $1.4 million in Q2 2025 and troughed at -$1.5 million in Q2 2024.
• A 5-year average of $43618.0 and a median of -$9372.0 in 2022 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables jumped 199.38% in 2023, then plunged 7519.08% in 2024.
• Over 5 years, Change in Account Payables stood at -$558665.0 in 2022, then jumped by 199.38% to $555208.0 in 2023, then fell by 26.47% to $408253.0 in 2024, then plunged by 146.05% to -$187989.0 in 2025, then soared by 64.28% to -$67158.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$67158.0, -$187989.0, and $324996.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.